Stock Analysts

Dow Chemical and Xgenex Partner to Sell WRS Technology

The Dow Chemical Company ’s ( DOW ) business unit — Dow Microbial Control — inked a commercial agreement with food safety company Xgenex LLC for selling Dow Advanced Oxidation System (AOS) certified Whole Room Sanitization (WRS) used in food processing and packaging environments. The AOS-certified WRS technology provides sustainable sanitization solution and can decrease and control pathogens both on surface and air. This system works by creating ozone vapor on demand out of surrounding air and water, eradicating the need for shipping and storing chemicals […]

Stock Analysts

Verizon FiOS Signs Deal to Add SEC Network

Verizon FiOS, a division of Verizon Communications Inc. ( VZ ), has collaborated with SEC Network and expects to air the latter’s services on its Channels 75 and 575, effective today. Post-launch, the service will be available on these channels to all FiOS TV customers in Florida and Texas who can access ESPN as part of their FiOS TV package and to FiOS Extreme and Ultimate customers on Channel 75 in all other markets […]

Stock Analysts

Noble Energy’s Gulf of Mexico Focus Yielding Results

Noble Energy Inc .’s ( NBL ) strategy to expand its operation in the resource rich Gulf of Mexico (GoM) has started to yield results. The company announced encouraging final well results at the Katmai exploration well and the Dantzler appraisal well in the deepwater GoM. Noble Energy has plans to spend $1.5 billion in its global deepwater operations in 2014, out of which a portion is earmarked for strengthening its GoM footprint […]

Stock Analysts

Aon Widens Coverage Options, Increases Elective Benefits

Aon plc’s ( AON ) global talent, retirement and health solutions unit, Aon Hewitt has declared the inclusion of a wide range of benefits in the coverage options under the Aon Active Health Exchange for 2015. The move marks the company’s effort to fulfill the increasing demand by organizations to provide additional benefits to employees. Employers are now keen to offer benefits that would not only be limited to medical and dental but would also support overall employee benefits […]

Stock Analysts

Eli Lilly-Boehringer Drug’s Cost Effectiveness Questioned

Eli Lilly and Company ( LLY ) and partner Boehringer Ingelheim are facing an issue related to Jardiance (empagliflozin) in the UK. The National Institute for Health and Care Excellence (NICE) has requested for additional information to validate that Jardiance is cost-effective in comparison with other treatment options already available in the market. […]